Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus

Lupus

Volumn 16, Issue 7, 2007, Pages 505-508

  Kasparian, A ^a   Floros, A ^a   Gialafos, E ^a   Kanakis, M ^a   Tassiopoulos, S ^a   Kafasi, N ^a   Vaiopoulos, George ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Raynaud phenomenon; Systemic lupus erythematosus; Systolic pulmonary arterial pressure

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; LUNG ARTERY PRESSURE; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY WEDGE PRESSURE; RAYNAUD DISEASE; SEVERITY OF ILLNESS INDEX; SYSTOLE; TIME FACTORS;

EID: 34547743338     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307080629     Document Type: Article

References (21)

1. Cervera R, Khamashta A, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period. A comparison of early and late manifestations in a cohort of 1000 patients. Medicine 2003; 82: 299-308.
2. Gaine SP, Rubin LG. Primary pulmonary hypertension. Lancet 1998; 352: 719-725.
3. Chen CH, Chen HA, Wang HP et al. Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan. J Microbiol Immunol Infect 2006; 39: 162-168.
4. Asherson RA, Hackett D, Gharavi AE et al. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases. J Rheumatol 1986; 13: 416-420.
5. Simonson JS, Schiller NB, Petri M et al. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989; 16: 918-925.
6. Winslow TM, Ossipov MA, Fazio GP et al. Five year follow up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995; 129: 510-515.
7. Tektonidou MG, Ioannidid JPA, Moyssakis I et al. Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome. Ann Rheum Dis 2001: 60: 43-48.
8. Khan F. Vascular abnormalities in Raynaud's phenomenon. Scott Med J 1999; 44: 4-6.
9. Joel Block, Winston Sequeira. Raynaud's Phenomenon. Lancet 2001; 357: 2042-2048.
10. Li Edmund, Lai-Shan Tam. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol 1999; 26:1923-1929.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
12. Yock PG, Popp RL. Noninvasive evaluation of intracardiac pressures using Doppler ultrasound: a case study of panvalvular regurgitation. Clin Cardiol 1985; 8: 565-571.
13. Grossman W, Braunwald E. Pulmonary hypertension. In Braunwald E, ed. Heart disease. A textbook of cardiovascular medicine. Philadelphia, WB: Saunders, 1988: 793.
14. Wysenbeek AJ, Leibovici L, Amit M, Weinberger A. Alopecia in systemic lupus erythematosus. Relation to disease manifestations. J Rheumatol 1991; 18(Suppl 8): 1185-1186.
15. Shen JY, Chen SL, Wu YX et al. Pulmonary hypertension in systemic lupus erythematosus. Rheumatol Int 1999; 18: 147-151.
16. Sakamoto K, Houya I, Inoue K et al. An imbalance in plasma prostanoids in patients with raynaud's phenomenon and pulmonary vasospasm. Eur Respir J 1999; 13:137-144.
17. Round S, Hill NS. Pulmonary hypertensive disease. Chest 1984; 85: 397-405.
18. Asherson RA, Oakley CM. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol 1990; 17: 1992-1998.
19. Tanaka E, Harigai M, Tanaka M et al. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to imunnosuppresive treatment. J Rheumatol 2002; 29: 282-287.
20. El-Magadmi M, Bodill H, Ahmad Y et al. Systemic lupus erythematosus. An independent risk factor for endothelial dysfunction in women. Circulation 2004; 110: 399-404.
21. Te Pan TL, Thumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 2000; 9: 338-342.